Clinical Trials Browser

Phase EARLY_PHASE1 × Desmoplastic Small Round Cell Tumor × Temozolomide × Clear all

NCT01189643 2025-09-05

Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor

Phase EARLY_PHASE1 Active not recruiting

Sarcoma, Desmoplastic Small Round Cell Tumor